Cargando…
Cancer Stem Cell Plasticity Drives Therapeutic Resistance
The connection between epithelial-mesenchymal (E-M) plasticity and cancer stem cell (CSC) properties has been paradigm-shifting, linking tumor cell invasion and metastasis with therapeutic recurrence. However, despite their importance, the molecular pathways involved in generating invasive, metastat...
Autores principales: | Doherty, Mary R., Smigiel, Jacob M., Junk, Damian J., Jackson, Mark W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728455/ https://www.ncbi.nlm.nih.gov/pubmed/26742077 http://dx.doi.org/10.3390/cancers8010008 |
Ejemplares similares
-
Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics
por: Smigiel, Jacob M., et al.
Publicado: (2018) -
The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer
por: Doherty, Mary R., et al.
Publicado: (2019) -
Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling
por: Junk, D J, et al.
Publicado: (2017) -
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer
por: Doherty, Mary R., et al.
Publicado: (2017) -
Balancing STAT Activity as a Therapeutic Strategy
por: Polak, Kelsey L., et al.
Publicado: (2019)